Douglas F. Kling serves as Executive at NewAmsterdam Pharma Co N.V., where they oversee executive responsibilities. Since joining the company, Douglas F. Kling has executed 5 insider transactions totaling $2.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 16, 2025 involved selling 51,043 shares valued at $1.1M.
Douglas F. Kling currently holds 44,000 shares of NewAmsterdam Pharma Co N.V. (NAMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas F. Kling has been a net seller of NAMS stock. They have purchased $0 and sold $2.1M worth of shares.
Douglas F. Kling's most recent insider trade was on Jul 16, 2025, when they sold 51,043 shares at $21.10 per share.
Get notified when new Form 4 filings are submitted
| $10.90 |
| Discretionary |
| Jul 15, 2025 | NAMS | $78.4K | Sale | 3,544 | $22.12 | Discretionary |
| Jul 15, 2025 | NAMS | $941.3K | Sale | 44,025 | $21.38 | Discretionary |
| Jul 15, 2025 | NAMS | $518.5K | Option Exercise | 47,569 | $10.90 | Discretionary |